Natural History of Breast Cancer

  • S. Gore
  • A. Langlands
  • S. Pocock
  • G. Kerr
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 80)

Summary

Retrospective analysis was made of 3,918 cases of breast cancer seen during 1954–1964. Median survival was 4.5 years and 30% of patients survived through a 10-year period. For stages I, II, and III patients, the mortality increased during 1–4 years after diagnosis and then slowly declined. Beyond 15 years, stage III patients assumed the same mortality (5%) as those with lesser disease; 58% excess of deaths from all causes after 15–20 years showed that breast cancer was not curable within 20 years but ultimately, taking account of clinical status, 51% of 5-year survivors with stages I-III disease are cured.

Keywords

Histiocytosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Armitage P, Geham EA (1974) Statistical methods for the identification and use of prognostic factors. Int J Cancer 13:16—36PubMedCrossRefGoogle Scholar
  2. 2.
    Baum M (1976) The curability of breast cancer. Br Med J I: 439–442Google Scholar
  3. 3.
    Berg JW, Robbins GF (1967) Failure of a model to predict cancer survival. J Chronic Dis 20:809–814PubMedCrossRefGoogle Scholar
  4. 4.
    Berkson J, Gage RP (1952) Survival curve for cancer patients following treatment. J Am Stat Assoc 47:501–515CrossRefGoogle Scholar
  5. 5.
    Boag JW (1949) Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J R Stat Soc [B] 11:15–44Google Scholar
  6. 6.
    Brinkley D, Haybittle JL (1977) The curability of breast cancer. World J Surg 1:287–289PubMedCrossRefGoogle Scholar
  7. 7.
    Cox DR (1972) Regression models and life-tables. J R Stat Soc [B] 34: 178–202Google Scholar
  8. 8.
    Cutler SJ, Myers MH (1967) Clinical classification of extent of disease in cancer of the breast. J Natl Cancer Inst 39:193–207PubMedGoogle Scholar
  9. 9.
    Easson EC, Russell MH (1968) The curability of cancer at various sites. Pitman, LondonGoogle Scholar
  10. 10.
    Greenwood M (1926) Natural duration of cancer. Her Majesty’s Stationary Office, London (Report on Public Health and Medical Subjects No 33)Google Scholar
  11. 11.
    Haybittle JL (1965) A two-parameter model for the survival curve of treated cancer patients. J Am Stat Assoc 60:16–26CrossRefGoogle Scholar
  12. 12.
    Haybittle JL (1968) Letter to the editor. Br J Radiol 41: 639PubMedCrossRefGoogle Scholar
  13. 13.
    Langlands AO, Pocock SJ, Kerr GR, Gore SM (1979) Long-term survival of patients with breast cancer: A study of the curability of the disease. Br Med J 2:1247–1251Google Scholar
  14. 14.
    Myers MH, Axtell LM, Zelen M (1966) The use of prognostic factors in predicting survival for breast cancer patients. J Chronic Dis 19:923–933PubMedCrossRefGoogle Scholar
  15. 15.
    Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer 35:1–39PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1982

Authors and Affiliations

  • S. Gore
    • 1
  • A. Langlands
    • 1
  • S. Pocock
    • 1
  • G. Kerr
    • 1
  1. 1.MRC Biostatics UnitMedical Research Council CentreCambridgeUK

Personalised recommendations